INTEGRA LIFESCIENCES HOLDINGS CORP Income (Loss) from Continuing Operations, Per Diluted Share
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.82 per share for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2018-03-01
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for the quarter ending 2016-12-31 was $0.35, a 75.00% increase year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for the quarter ending 2016-09-30 was $0.25.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for the quarter ending 2016-06-30 was $0.16, a 11.11% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for the quarter ending 2016-03-31 was $0.18, a 0.00% change year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for fiscal 2017 was $0.82, a 12.77% decline from fiscal 2016.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for fiscal 2016 was $0.94, a 840.00% increase from fiscal 2015.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for fiscal 2015 was $0.10, a 81.82% decline from fiscal 2014.
- INTEGRA LIFESCIENCES HOLDINGS CORP income (loss) from continuing operations, per diluted share for fiscal 2014 was $0.55, a 27.63% decline from fiscal 2013.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month | Income (Loss) from Continuing Operations, Per Diluted Share 12 month as first filed |
|---|---|---|---|---|---|---|
| 2017-12-31 | $0.82 10-K · filed 2018-03-01 | |||||
| 2016-12-31 | $0.35 10-K · filed 2017-02-23 | $0.94 10-K · filed 2018-03-01 | ||||
| 2016-09-30 | $0.25 10-K · filed 2017-02-23 | $0.50 10-Q · filed 2016-10-28 | $1.18 10-Q · filed 2016-10-28 | |||
| 2016-06-30 | $0.16 10-K · filed 2017-02-23 | $0.32 10-Q · filed 2016-07-28 | $0.68 10-Q · filed 2016-07-28 | |||
| 2016-03-31 | $0.18 10-K · filed 2017-02-23 | $0.31 10-Q · filed 2016-04-27 | ||||
| 2015-12-31 | $0.20 10-K · filed 2017-02-23 | $0.39 10-K · filed 2016-02-26 | $0.10 10-K · filed 2018-03-01 | $0.19 10-K · filed 2016-02-26 | ||
| 2015-09-30 | -$0.45 10-K · filed 2017-02-23 | -$0.90 10-Q · filed 2015-11-04 | -$0.24 10-Q · filed 2016-10-28 | |||
| 2015-06-30 | $0.18 10-K · filed 2017-02-23 | $0.35 10-K · filed 2016-02-26 | $0.71 10-Q · filed 2016-07-28 | |||
| 2015-03-31 | $0.18 10-K · filed 2017-02-23 | $0.35 10-K · filed 2016-02-26 | ||||
| 2014-12-31 | $0.62 10-K · filed 2016-02-26 | $0.52 10-K · filed 2015-02-27 | $0.55 10-K · filed 2017-02-23 | $1.10 10-K · filed 2016-02-26 | ||
| 2014-09-30 | $0.27 10-K · filed 2016-02-26 | $0.30 10-K · filed 2015-02-27 | $0.48 10-Q · filed 2015-11-04 | |||
| 2014-06-30 | $0.13 10-K · filed 2016-02-26 | $0.15 10-K · filed 2015-02-27 | ||||
| 2014-03-31 | $0.08 10-K · filed 2016-02-26 | $0.07 10-K · filed 2015-02-27 | ||||
| 2013-12-31 | $0.45 10-K · filed 2015-02-27 | $0.40 10-K · filed 2014-02-27 | $0.76 10-K · filed 2016-02-26 | |||
| 2013-09-30 | -$1.09 10-K · filed 2015-02-27 | -$1.02 10-K · filed 2014-02-27 | ||||
| 2013-06-30 | $0.05 10-K · filed 2015-02-27 | $0.12 10-K · filed 2014-02-27 | ||||
| 2013-03-31 | -$0.22 10-K · filed 2015-02-27 | -$0.15 10-K · filed 2014-02-27 | ||||
| 2012-12-31 | $0.46 8-K · filed 2014-06-20 | |||||
| 2012-09-30 | $0.46 8-K · filed 2014-06-20 | |||||
| 2012-06-30 | $0.30 8-K · filed 2014-06-20 | |||||
| 2012-03-31 | $0.23 8-K · filed 2014-06-20 | |||||
| 2011-12-31 | $0.16 10-K · filed 2013-02-26 | |||||
| 2011-09-30 | $0.39 10-K · filed 2013-02-26 | |||||
| 2011-06-30 | $0.02 10-K · filed 2013-02-26 | |||||
| 2011-03-31 | $0.38 10-K · filed 2013-02-26 | |||||
| 2010-12-31 | $0.63 10-K · filed 2012-02-27 | |||||
| 2010-09-30 | $0.55 10-K · filed 2012-02-27 | |||||
| 2010-06-30 | $0.50 10-K · filed 2012-02-27 | |||||
| 2010-03-31 | $0.50 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |